Phase 1 study of CS-7017 in combination with FOLFIRI
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/100185
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: investigational material(s)
Generic name etc : CS-7017
INN of investigational material : efatutazone
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material : CS-7017(0.25-0.50 mg) administered orally twice a day
Primary outcome(s): Safety and Pharmacokinetics
-To evaluate the safety profile according to CTCAE
-To evaluate the pharmacokinetics according to the protocol
Study Design: Open Label Phase 1 Study
创建时间：
2010-08-15
